[Oropharyngeal candidiasis and radiotherapy]

Cancer Radiother. 2012 May;16(3):222-9. doi: 10.1016/j.canrad.2011.11.004. Epub 2012 Apr 24.
[Article in French]

Abstract

The oropharyngeal candidiasis is a common condition in cancer patients treated by irradiation, during and after their treatment. For example, almost 70% of patients treated with chemoradiation for head and neck cancer are colonized, and 40% of symptomatic patients have an oropharyngeal candidiasis. Furthermore, we noticed an increase in non-albicans Candida strains, which are present in almost 50% of samples. Cancer treatments, especially radiation therapy, and comorbidities are risk factors of oropharyngeal candidiasis. Oropharyngeal candidiasis has substantial effects on quality of life, and may limit treatment. Epidemiologic data, physiopathology, clinical diagnosis criteria, consequences and treatment of oropharyngeal candidiasis will be discussed in this article.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Candidiasis / diagnosis
  • Candidiasis / microbiology*
  • Candidiasis / therapy
  • Candidiasis, Oral / diagnosis
  • Candidiasis, Oral / microbiology*
  • Candidiasis, Oral / therapy
  • Humans
  • Pharyngeal Diseases / diagnosis
  • Pharyngeal Diseases / microbiology*
  • Pharyngeal Diseases / therapy
  • Radiotherapy / adverse effects*
  • Xerostomia / etiology